Aquadex Smartflow Console
Device Cardiology
PDI 10853072007104
General payments
$1,581,566
Research payments
$757,318
Through program year 2025, $1,581,566 in general payments and $757,318 in research payments were reported against Aquadex Smartflow Console (Cardiology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $192,022 | 186 |
| 2025 | Research | $285,292 | 63 |
| 2024 | General | $242,758 | 251 |
| 2024 | Research | $205,032 | 81 |
| 2023 | General | $385,795 | 319 |
| 2023 | Research | $204,063 | 28 |
| 2022 | General | $215,058 | 222 |
| 2022 | Research | $62,931 | 8 |
| 2021 | General | $545,933 | 456 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 19 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,434 general · 180 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.